中关村：下属公司盐酸羟考酮缓释片上市申请获受理

Core Viewpoint - The company Zhongguancun (000931) announced that its subsidiary Beijing Huasu Pharmaceutical Co., Ltd. has received a "Notice of Acceptance" from the National Medical Products Administration for the listing application of Oxycodone Hydrochloride Controlled-Release Tablets (40mg) [1] Group 1 - The Oxycodone Hydrochloride Controlled-Release Tablets are clinically used for treating severe pain that requires long-term, consistent use of opioid medications, where alternative treatments are insufficient [1]